Skip to main content
Erschienen in: Supportive Care in Cancer 8/2013

01.08.2013 | Original Article

Distress screening remains important during follow-up after primary breast cancer treatment

verfasst von: Floortje K. Ploos van Amstel, Sanne W. van den Berg, Hanneke W. M. van Laarhoven, Marieke F. M. Gielissen, Judith B. Prins, Petronella B. Ottevanger

Erschienen in: Supportive Care in Cancer | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

To improve psychosocial care, the National Comprehensive Cancer Network recommends the use of the Distress Thermometer (DT) to detect distress among cancer patients.

Objectives

The objectives of this study were to describe the prevalence of distress in breast cancer survivors (BCSs) and to investigate demographic, treatment, and psychosocial variables associated with distress and problems most often reported on the problem list. Moreover, we assessed how many BCSs requested referral to a professional for additional support.

Methods

In a cross-sectional study, 258 BCSs identified at an outpatient clinic of a university hospital were asked to complete the following questionnaires: DT, Quality of Life Questionnaire, Hospital Anxiety and Depression Scale, and Illness Cognition Questionnaire.

Results

Of the 258 identified BCSs, 129 (50 %) completed all questionnaires. After a mean follow-up period of 5.6 (SD, 10) years, 47 (36 %) of these 129 BCSs experienced distress as assessed by the DT. BCSs experienced significantly more distress in the first 2 years than in the period between 2 and 5 years after surgery. Also, more distress was experienced in BCSs treated with surgery, radiotherapy, and chemotherapy compared to those treated with surgery only. Problems most frequently encountered were fatigue (57 %), decrease in muscle strength (47 %), and lack of physical fitness (42 %). Thirty one (69 %) of the distressed BCSs requested or considered referral to a professional. Regression analysis showed that reduced quality of life, reduced cognitive function, and fatigue were predictors of distress.

Conclusion

The current study found that more than one third of all BCSs experienced distress. Screening remains an important part of BCSs' care. The professional should be aware of the potential problems and distress patients may experience.
Literatur
1.
Zurück zum Zitat Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917PubMedCrossRef Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917PubMedCrossRef
2.
Zurück zum Zitat Dutch Cancer Society (2011) Cancer in the Netherlands until 2020. Dutch Cancer Society, Amsterdam Dutch Cancer Society (2011) Cancer in the Netherlands until 2020. Dutch Cancer Society, Amsterdam
3.
Zurück zum Zitat Montazeri A (2008) Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res 27:32PubMedCrossRef Montazeri A (2008) Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res 27:32PubMedCrossRef
4.
Zurück zum Zitat Peuckmann V, Ekholm O, Rasmussen NK et al (2009) Chronic pain and other sequelae in long-term breast cancer survivors: nationwide survey in Denmark. Eur J Pain 13(5):478–485PubMedCrossRef Peuckmann V, Ekholm O, Rasmussen NK et al (2009) Chronic pain and other sequelae in long-term breast cancer survivors: nationwide survey in Denmark. Eur J Pain 13(5):478–485PubMedCrossRef
5.
Zurück zum Zitat Servaes P, Verhagen S, Bleijenberg G (2002) Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study. Ann Oncol 13(4):589–598PubMedCrossRef Servaes P, Verhagen S, Bleijenberg G (2002) Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study. Ann Oncol 13(4):589–598PubMedCrossRef
6.
Zurück zum Zitat Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR (2002) Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. Natl Cancer Inst 2 94(1):39–49CrossRef Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR (2002) Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. Natl Cancer Inst 2 94(1):39–49CrossRef
7.
Zurück zum Zitat Costanzo ES, Lutgendorf SK, Mattes ML et al (2007) Adjusting to life after treatment: distress and quality of life following treatment for breast cancer. Br J Cancer 97(12):1625–1631PubMedCrossRef Costanzo ES, Lutgendorf SK, Mattes ML et al (2007) Adjusting to life after treatment: distress and quality of life following treatment for breast cancer. Br J Cancer 97(12):1625–1631PubMedCrossRef
8.
Zurück zum Zitat Garofalo JP, Choppala S, Hamann HA, Gjerde J (2009) Uncertainty during the transition from cancer patient to survivor. Cancer Nurs 32(4):E8–E14PubMedCrossRef Garofalo JP, Choppala S, Hamann HA, Gjerde J (2009) Uncertainty during the transition from cancer patient to survivor. Cancer Nurs 32(4):E8–E14PubMedCrossRef
9.
Zurück zum Zitat Stanton AL (2012) What happens now? Psychosocial care for cancer survivors after medical treatment completion. J Clin Oncol 30(11):1215–1220PubMedCrossRef Stanton AL (2012) What happens now? Psychosocial care for cancer survivors after medical treatment completion. J Clin Oncol 30(11):1215–1220PubMedCrossRef
10.
Zurück zum Zitat Lavigne JE, Griggs JJ, Tu XM, Lerner DJ (2008) Hot flashes, fatigue, treatment exposures and work productivity in breast cancer survivors. J Cancer Surviv 2(4):296–302PubMedCrossRef Lavigne JE, Griggs JJ, Tu XM, Lerner DJ (2008) Hot flashes, fatigue, treatment exposures and work productivity in breast cancer survivors. J Cancer Surviv 2(4):296–302PubMedCrossRef
11.
Zurück zum Zitat Hansen JA, Feuerstein M, Calvio LC, Olsen CH (2008) Breast cancer survivors at work. J Occup Environ Med 50(7):777–784PubMedCrossRef Hansen JA, Feuerstein M, Calvio LC, Olsen CH (2008) Breast cancer survivors at work. J Occup Environ Med 50(7):777–784PubMedCrossRef
12.
Zurück zum Zitat National Comprehensive Cancer Network (2011) NCCN clinical practice guidelines in oncology: distress management. US. National Comprehensive Cancer Network (2011) NCCN clinical practice guidelines in oncology: distress management. US.
13.
Zurück zum Zitat Lazarus R, Folkman S (1984) Stress, appraisal, and coping. Springer, New York Lazarus R, Folkman S (1984) Stress, appraisal, and coping. Springer, New York
14.
Zurück zum Zitat Vitek L, Rosenzweig MQ, Stollings S (2007) Distress in patients with cancer: definition, assessment, and suggested interventions. Clin J Oncol Nurs 11(3):413–418PubMedCrossRef Vitek L, Rosenzweig MQ, Stollings S (2007) Distress in patients with cancer: definition, assessment, and suggested interventions. Clin J Oncol Nurs 11(3):413–418PubMedCrossRef
15.
Zurück zum Zitat Ryan H, Schofield P, Cockburn J et al (2005) How to recognize and manage psychological distress in cancer patients. Eur J Cancer Care 14(1):7–15CrossRef Ryan H, Schofield P, Cockburn J et al (2005) How to recognize and manage psychological distress in cancer patients. Eur J Cancer Care 14(1):7–15CrossRef
16.
Zurück zum Zitat Falagas M, Zarkadoulia E, Ioannidou E, Peppas G, Christodoulou C, Rafailidis P (2007) The effect of psychosocial factors on breast cancer outcome: a systematic review. Breast Cancer Research 9:4CrossRef Falagas M, Zarkadoulia E, Ioannidou E, Peppas G, Christodoulou C, Rafailidis P (2007) The effect of psychosocial factors on breast cancer outcome: a systematic review. Breast Cancer Research 9:4CrossRef
17.
Zurück zum Zitat Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A (2005) Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ 330(7493):702PubMedCrossRef Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A (2005) Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ 330(7493):702PubMedCrossRef
18.
Zurück zum Zitat Evers AWM, Kraaimaat FW, van Lankveld W, Jongen PJH, Jacobs JWG, Bijlsma JWJ (2001) Beyond unfavorable thinking: the illness cognition questionnaire for chronic diseases. J Consult Clin Psychol 69:1026–1036PubMedCrossRef Evers AWM, Kraaimaat FW, van Lankveld W, Jongen PJH, Jacobs JWG, Bijlsma JWJ (2001) Beyond unfavorable thinking: the illness cognition questionnaire for chronic diseases. J Consult Clin Psychol 69:1026–1036PubMedCrossRef
19.
Zurück zum Zitat Stanton AL, Ganz PA, Rowland JH, Meyerowitz BE, Krupnick JL, Sears SR (2005) Promoting adjustment after treatment for cancer. Cancer 104(11):2608–2613PubMedCrossRef Stanton AL, Ganz PA, Rowland JH, Meyerowitz BE, Krupnick JL, Sears SR (2005) Promoting adjustment after treatment for cancer. Cancer 104(11):2608–2613PubMedCrossRef
20.
Zurück zum Zitat Holland JC, Reznik I (2005) Pathways for psychosocial care of cancer survivors. Cancer suppl 104(11) Holland JC, Reznik I (2005) Pathways for psychosocial care of cancer survivors. Cancer suppl 104(11)
21.
Zurück zum Zitat Henselmans I, Helgeson VS, Seltman H, de Vries J, Sanderman R, Ranchor AV (2010) Identification and prediction of distress trajectories in the first year after a breast cancer diagnosis. Health Psychol 29(2):160–168PubMedCrossRef Henselmans I, Helgeson VS, Seltman H, de Vries J, Sanderman R, Ranchor AV (2010) Identification and prediction of distress trajectories in the first year after a breast cancer diagnosis. Health Psychol 29(2):160–168PubMedCrossRef
22.
Zurück zum Zitat Helgeson VS, Snyder P, Seltman H (2004) Psychological and physical adjustment to breast cancer over 4 years: identifying distinct trajectories of change. Health Psychol 2004 23(1):3–15 Helgeson VS, Snyder P, Seltman H (2004) Psychological and physical adjustment to breast cancer over 4 years: identifying distinct trajectories of change. Health Psychol 2004 23(1):3–15
23.
Zurück zum Zitat Hinnen C, Ranchor AV, Sanderman R, Snijders TAB, Hagedoorn M, Coyne JC (2008) Course of distress in breast cancer patients, their partners, and matched control couples. Ann Behav Med 36(2):141–148PubMedCrossRef Hinnen C, Ranchor AV, Sanderman R, Snijders TAB, Hagedoorn M, Coyne JC (2008) Course of distress in breast cancer patients, their partners, and matched control couples. Ann Behav Med 36(2):141–148PubMedCrossRef
24.
Zurück zum Zitat Bauwens S, Baillon C, Distelmans W, Theuns P (2009) The ‘Distress Barometer’: validation of method of combining the distress thermometer with a rated complaint scale. Psycho-Oncology 18(5):534–542PubMedCrossRef Bauwens S, Baillon C, Distelmans W, Theuns P (2009) The ‘Distress Barometer’: validation of method of combining the distress thermometer with a rated complaint scale. Psycho-Oncology 18(5):534–542PubMedCrossRef
25.
Zurück zum Zitat Tuinman MA, Gazendam-Donofrio SM, Hoekstra-Weebers JE (2008) Screening and referral for psychosocial distress in oncologic practice: use of the distress thermometer. Cancer 113(4):870–878PubMedCrossRef Tuinman MA, Gazendam-Donofrio SM, Hoekstra-Weebers JE (2008) Screening and referral for psychosocial distress in oncologic practice: use of the distress thermometer. Cancer 113(4):870–878PubMedCrossRef
26.
Zurück zum Zitat Gessler S, Low J, Daniells E, Williams R, Brough V, Tookman A, Jones L (2008) Screening for distress in cancer patients: is the distress thermometer a valid measure in the UK and does it measure change over time? A prospective validation study. Psycho-Oncology 17(6):538–547PubMedCrossRef Gessler S, Low J, Daniells E, Williams R, Brough V, Tookman A, Jones L (2008) Screening for distress in cancer patients: is the distress thermometer a valid measure in the UK and does it measure change over time? A prospective validation study. Psycho-Oncology 17(6):538–547PubMedCrossRef
27.
Zurück zum Zitat Ransom S, Jacobsen PB, Booth-Jones M (2006) Validation of the distress thermometer with bone marrow transplant patients. Psycho-Oncology 15(7):604–612PubMedCrossRef Ransom S, Jacobsen PB, Booth-Jones M (2006) Validation of the distress thermometer with bone marrow transplant patients. Psycho-Oncology 15(7):604–612PubMedCrossRef
28.
Zurück zum Zitat Jacobsen PB, Donovan KA, Trask PC et al (2005) Screening for psychologic distress in ambulatory cancer patients. Cancer 103(7):1494–1502PubMedCrossRef Jacobsen PB, Donovan KA, Trask PC et al (2005) Screening for psychologic distress in ambulatory cancer patients. Cancer 103(7):1494–1502PubMedCrossRef
29.
Zurück zum Zitat Hoffman BM, Zevon MA, D'Arrigo MC, Cecchini TB (2004) Screening for distress in cancer patients: the NCCN rapid-screening measure. Psycho-Oncology 13(11):792–799PubMedCrossRef Hoffman BM, Zevon MA, D'Arrigo MC, Cecchini TB (2004) Screening for distress in cancer patients: the NCCN rapid-screening measure. Psycho-Oncology 13(11):792–799PubMedCrossRef
30.
Zurück zum Zitat Gil F, Grassi L, Travado L, Tomamichel M, Gonzalez JR (2005) Use of distress and depression thermometers to measure psychosocial morbidity among southern European cancer patients. Support Care Cancer 13(8):600–606PubMedCrossRef Gil F, Grassi L, Travado L, Tomamichel M, Gonzalez JR (2005) Use of distress and depression thermometers to measure psychosocial morbidity among southern European cancer patients. Support Care Cancer 13(8):600–606PubMedCrossRef
31.
Zurück zum Zitat Dutch Association of Comprehensive Cancer Centers (2010) Guideline: detection of need for psychosocial care, the Netherlands. Dutch Association of Comprehensive Cancer Centers (2010) Guideline: detection of need for psychosocial care, the Netherlands.
32.
Zurück zum Zitat Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370PubMedCrossRef Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361–370PubMedCrossRef
33.
Zurück zum Zitat Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res 52(2):69–77PubMedCrossRef Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res 52(2):69–77PubMedCrossRef
34.
Zurück zum Zitat Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM (1997) A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 27(2):363–370PubMedCrossRef Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM (1997) A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 27(2):363–370PubMedCrossRef
35.
Zurück zum Zitat Aaronson N, Ahmedzai A, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30. Journal Natl Cancer Inst 85(5):365–376CrossRef Aaronson N, Ahmedzai A, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30. Journal Natl Cancer Inst 85(5):365–376CrossRef
36.
Zurück zum Zitat Osoba D, Aaronson N, Zee B, Sprangers M, te Velde A (1997) Modification of the EORTC QLQ-C30 (version 2.0) based on content validity and reliability testing in large samples of patients with cancer. The Study Group on Quality of Life of the EORTC and the Symptom Control and Quality of Life Committees of the NCI of Canada Clinical Trials Group. Qual Life Res 6(2):103–108PubMedCrossRef Osoba D, Aaronson N, Zee B, Sprangers M, te Velde A (1997) Modification of the EORTC QLQ-C30 (version 2.0) based on content validity and reliability testing in large samples of patients with cancer. The Study Group on Quality of Life of the EORTC and the Symptom Control and Quality of Life Committees of the NCI of Canada Clinical Trials Group. Qual Life Res 6(2):103–108PubMedCrossRef
37.
Zurück zum Zitat Sprangers MA, Groenvold M, Arraras JI et al (1996) The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 14(10):2756–2768PubMed Sprangers MA, Groenvold M, Arraras JI et al (1996) The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 14(10):2756–2768PubMed
38.
Zurück zum Zitat Greimel E, Bottomley A, Cull A et al (2003) An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer. Eur J Cancer 39(10):1402–1408PubMedCrossRef Greimel E, Bottomley A, Cull A et al (2003) An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer. Eur J Cancer 39(10):1402–1408PubMedCrossRef
39.
Zurück zum Zitat Evers A, Kraaimaat F, Wv L, Jacobs W, Bijlsma J (1998) De ziekte-cognitie-lijst (ZCL). Gedragstherapie 31:205–220 Evers A, Kraaimaat F, Wv L, Jacobs W, Bijlsma J (1998) De ziekte-cognitie-lijst (ZCL). Gedragstherapie 31:205–220
41.
Zurück zum Zitat Phipps AI, Ichikawa L, Bowles EJ et al (2010) Defining menopausal status in epidemiologic studies: a comparison of multiple approaches and their effects on breast cancer rates. Maturitas 67(1):60–66PubMedCrossRef Phipps AI, Ichikawa L, Bowles EJ et al (2010) Defining menopausal status in epidemiologic studies: a comparison of multiple approaches and their effects on breast cancer rates. Maturitas 67(1):60–66PubMedCrossRef
42.
Zurück zum Zitat Tabuchnink BG, Fidell LS (2007) Using multivariate analysis, 5th edn. Pearson Education, Boston Tabuchnink BG, Fidell LS (2007) Using multivariate analysis, 5th edn. Pearson Education, Boston
43.
Zurück zum Zitat Bower JE, Ganz PA, Desmond KA et al (2006) Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer 106(4):751–758PubMedCrossRef Bower JE, Ganz PA, Desmond KA et al (2006) Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer 106(4):751–758PubMedCrossRef
44.
Zurück zum Zitat Norton S, Cosco T, Doyle F, Done J,Sacker A (2013) The hospital anxiety and depression scale: a meta confirmatory factor analysis. J Psychosom Res 74(1):74–81 Norton S, Cosco T, Doyle F, Done J,Sacker A (2013) The hospital anxiety and depression scale: a meta confirmatory factor analysis. J Psychosom Res 74(1):74–81
Metadaten
Titel
Distress screening remains important during follow-up after primary breast cancer treatment
verfasst von
Floortje K. Ploos van Amstel
Sanne W. van den Berg
Hanneke W. M. van Laarhoven
Marieke F. M. Gielissen
Judith B. Prins
Petronella B. Ottevanger
Publikationsdatum
01.08.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 8/2013
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-013-1764-0

Weitere Artikel der Ausgabe 8/2013

Supportive Care in Cancer 8/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.